Mr. Shaun Flanagan:

Consultants make an application to Professor Barry's programme and it is a relatively simple screening programme. Once they qualify, the consultant will be told that the HSE primary reimbursement service will carry the cost of eculizumab. I know one process patient has been through it and has definitively started therapy. There are four other applications. It is down to people completing forms and getting through the process. There is no attempt to slow it down, in case Deputies have concerns.

I have never been involved in a sweetheart deal, nor have I ever seen one.